Literature DB >> 12402052

Harmonic scalpel hemorrhoidectomy: preliminary results of a new alternative method.

E Ramadan1, T Vishne, Z Dreznik.   

Abstract

Surgical treatment is considered to be the best therapeutic modality for severe hemorrhoidal disease. Different surgical methods of hemorrhoidectomy aim to decrease pain, bleeding, stenosis and discharge. The aim of this study was to evaluate the efficacy of harmonic scalpel hemorrhoidectomy. During a period of seven months, 54 consecutive patients with third- and fourth-degree hemorrhoids were prospectively randomized for harmonic scalpel hemorrhoidectomy (HS) or Milligan-Morgan procedure (MM). These patients were examined at one, two, and six weeks after the operation. All patients had a lower gastrointestinal investigation prior to operation to exclude other colorectal pathologies. All patients had the same kind of preoperative preparation and analgesia during the postoperative course. Pain was assessed using a visual analog scale from 0 to 10. Patient satisfaction was defined as decrease or absence of symptoms and return to normal daily activities. HS groups included 29 patients, while the MM group had 25 patients. There as no difference between the groups in terms of age, gender, hemorrhoidal degree and indication for operation. The types of intra-operative anesthesia administered to the two groups were similar. Duration of surgery was significantly higher in the MM group ( p<0.0001). Postoperative hospitalization was longer in the MM group ( p<0.0001), and the pain degree was higher in MM group ( p<0.0001). No significant difference was noted in the overall amount of analgesics used in the two groups at week 1, although it was significantly higher in the MM group 2 and 3 weeks after the operation. Early complication occurred more frequently in the MM group but overall the difference was not statistically significant. In conclusion, harmonic scalpel hemorrhoidectomy is virtually a bloodless operation with minimal tissue damage. It is associated with significant less postoperative pain and a fast return to normal activity.

Entities:  

Mesh:

Year:  2002        PMID: 12402052     DOI: 10.1007/s101510200019

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  6 in total

1.  Simple harmonic scalpel hemorrhoidectomy utilizing local anesthesia combined with intravenous sedation: a safe and rapid alternative to conventional hemorrhoidectomy.

Authors:  Liam A Haveran; Paul R Sturrock; Mark Y Sun; Janet McDade; Sudershan Singla; Craig A Paterson; Timothy C Counihan
Journal:  Int J Colorectal Dis       Date:  2006-11-22       Impact factor: 2.571

Review 2.  Harmonic scalpel compared with conventional excisional haemorrhoidectomy: a meta-analysis of randomized controlled trials.

Authors:  C D Mushaya; P J Caleo; L Bartlett; P G Buettner; Y H Ho
Journal:  Tech Coloproctol       Date:  2014-06-13       Impact factor: 3.781

3.  How we can improve patients' comfort after Milligan-Morgan open haemorrhoidectomy.

Authors:  Ma-Mu-Ti-Jiang A Ba-bai-ke-re; Hong-Guo Huang; Wen-Ni Re; Kai Fan; Hui Chu; Er-Ha-Ti Ai; Mai-Mai-Ti-Tu-Er-Xun Ke Li-Mu; Yi-Rui Wang; Hao Wen
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

4.  Prospective randomized trial comparing stapled hemorrhoidopexy versus closed Ferguson hemorrhoidectomy.

Authors:  K S Ho; Y H Ho
Journal:  Tech Coloproctol       Date:  2006-09-20       Impact factor: 3.781

5.  Linear Pinched Hemorrhoidectomy: A Retrospective Observational Study (An Innovative, Simplified Hemorrhoidectomy).

Authors:  Akiharu Kurihara; Yu Yoshino; Yu Sakai; Yasuyuki Miura; Satoru Kagami; Tomoaki Kaneko; Mitsunori Ushigome; Hiroyuki Shiokawa; Hironori Kaneko; Kimihiko Funahashi
Journal:  J Anus Rectum Colon       Date:  2021-07-29

6.  Internal sphincterotomy reduces postoperative pain after Milligan Morgan haemorrhoidectomy.

Authors:  Giuseppe Diana; Giovanni Guercio; Bianca Cudia; Calogero Ricotta
Journal:  BMC Surg       Date:  2009-10-24       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.